Avenue Therapeutics(ATXI)
$0.280.00 (0.00%)
ATXI
Avenue Therapeutics financials statements
$0.28
At close:0.00 (0.00%)
Want to see ATXI full AI Analyst Report?
Avenue Therapeutics (ATXI) Income Statement
334 Followers
Avenue Therapeutics Income Statement
Last quarter (Q3 2026), Avenue Therapeutics's total revenue was $0.00. In Q3, Avenue Therapeutics's net income was $-691.00K. See Avenue Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.40M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 1.40M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 4.69M | $ 11.28M | $ 14.54M | $ 8.04M | $ 3.74M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 14.54M | $ 0.00 | $ 3.74M |
| $ -3.29M | $ -11.70M | $ 4.05M | $ -2.44M | $ 7.00K | |
| $ -3.29M | $ -11.28M | $ -14.54M | $ -8.04M | $ -3.74M | |
| $ 339.00K | $ -413.00K | $ 4.05M | $ 4.44M | $ 7.00K | |
| $ -2.95M | $ -11.70M | $ -10.49M | $ -3.60M | $ -3.73M | |
| $ -2.91M | $ -11.65M | $ -10.38M | $ -3.55M | $ -3.73M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.93 | $ -0.90 | $ -73.60 | $ -121.91 | $ -3.29 |
| Diluted EPS | $ -0.93 | $ -0.90 | $ -73.48 | $ -121.91 | $ -3.29 |
| Weighted Average Shares Outstanding | 3.13M | 12.95M | 141.00K | 29.14K | 1.13M |
| Weighted Average Shares Outstanding (Diluted) | 3.13M | 12.95M | 141.22K | 29.14K | 1.13M |
Currency in USD

